Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03038100 |
|---|---|
| Brief Title: | A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (IMagyn050) |
| First Submitted : | January 30, 2017 |
| First Submitted that Met QC Criteria : | January 30, 2017 |
| First Posted : | January 31, 2017 (Estimate) |
| Last Update Submitted that Met QC Criteria : | November 7, 2022 |
| Last Update Posted : | November 9, 2022 |